Detalles de la búsqueda
1.
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: impact of HLA class I antigen expression on outcome.
J Clin Oncol
; 20(8): 2067-75, 2002 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956267
2.
Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.
J Clin Oncol
; 20(8): 2058-66, 2002 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11956266
3.
Adjuvant vaccine immunotherapy of resected, clinically node-negative melanoma: long-term outcome and impact of HLA class I antigen expression on overall survival.
Cancer Immunol Res
; 2(10): 981-7, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24994597
Resultados
1 -
3
de 3
1
Próxima >
>>